CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

RET fusion

Gene: RET · Type: fusion

Indications: Non-small cell lung cancer, Thyroid cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
SelpercatinibNon-small cell lung cancer, Thyroid cancerINDICATED
FDA Label
Label
PralsetinibNon-small cell lung cancer, Thyroid cancerINDICATED
FDA Label
Label